Aperam PK (APEMY)

Aperam PK (APEMY) is an OTC Markets depositary receipt linked to Aperam S.A., a Luxembourg-based materials company incorporated in 2010. The underlying issuer produces and sells stainless steel and alloy products globally, with operations organized across Stainless & Electrical Steel, Services & Solutions, Alloys & Specialties, and Recycling & Renewables. Its product range includes stainless steel, flat stainless and electrical steel, special carbon products, and specialty-grade alloys, along with tubes and customized steel solutions. Aperam also collects, trades, processes, and recycles stainless steel scrap and high-performance alloys. The company serves industries such as aerospace, automotive, construction, medical, and oil and gas, and distributes products through steel service centers, transformation facilities, and sales offices.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-APEM.Y
$47.26
-10.8% Downside
Fair
Not available
Not available
Good
November 16, 2026
December 10, 2026
3.8%
November 6, 2026
26.3x
1.0x
0.6x
3.726 B
4.964 B
28.3%
59.3%
7.2
115.0%
243.3%
Valuation • Fair Value

Aperam PK (OTC-APEM.Y) Fair Value by Valuation Model

Review the available estimates for Aperam PK (OTC-APEM.Y), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$47.26

Estimated downside of 10.8% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$46.23

Discounted cash flow valuation reference.

Ben Graham Formula Value

$22.34

Classic Ben Graham valuation formula reference.

DDM Fair Value

$60.52

Dividend discount model valuation reference.

Comps Fair Value

$43.88

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Aperam PK (OTC-APEM.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Aperam PK (OTC-APEM.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.888 B

Current operating scale indicator.

Revenue Forecast

7.522 B

Forward revenue estimate.

EBITDA

326.6 M

Current operating profitability reference.

EBITDA Forecast

575.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Aperam PK (OTC-APEM.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Aperam PK (OTC-APEM.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.69

No elevated caution signal from this screen.

Altman Z-Score

7.2

Relatively strong balance-sheet zone.

FCF / Net Income

243.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Aperam PK (OTC-APEM.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Aperam PK (OTC-APEM.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 6, 2026

Days to Earnings

49

Dividend Payment Date

December 10, 2026

Ex-Dividend Date

November 16, 2026

Dividend Yield

3.8%

Current income yield reference.

Payout Ratio

115.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Aperam PK (OTC-APEM.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Aperam PK (OTC-APEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Aperam PK (OTC-APEM.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Aperam PK (OTC-APEM.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Aperam PK (OTC-APEM.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Aperam PK (OTC-APEM.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Aperam PK (OTC-APEM.Y) Stock FAQ

Data-supported answers about Aperam PK (OTC-APEM.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$47.26
Estimated downside 10.8%
Valuation Rating
Overvalued
Estimated downside of 10.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Aperam PK (OTC-APEM.Y) is $47.26. This implies an estimated downside of 10.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 10.8% versus the current market price.

The current financial health read for Aperam PK (OTC-APEM.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Aperam PK (OTC-APEM.Y) is November 6, 2026.

Based on the current data, dividend yield is 3.8%, ex-dividend date is November 16, 2026, payment date is December 10, 2026.

The current P/E ratio listed for Aperam PK (OTC-APEM.Y) is 26.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Aperam PK is 3.726 B.

The current enterprise value listed for Aperam PK is 4.964 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Aperam PK is OTC-APEM.Y, and the stock is listed on OTC Markets.

Aperam PK (OTC-APEM.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Aperam PK is 28.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Aperam PK is 59.3%. Free float helps investors understand how much of the share base is available for public trading.